The PI3k/Akt pathway is downstream of the common growth factor receptor tyrosine kinases (RTKs), including EGFR, HER2, and IGFR, and is a likely driver of tumor progression in most carcinomas8, 9, 10. Here, AKT1 is linked to neoplasm.